A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Completed · Phase 3 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

The objective of this trial is to evaluate the safety and efficacy of Xyrem® compared to placebo for the treatment of fibromyalgia in a randomized, double blind, placebo controlled, parallel group trial.

Key facts

Study ID
NCT00423813
Run by
Jazz Pharmaceuticals
People needed
573
Starts
2006-12-01
Expected to finish
2009-06-01
Last updated by the study team
2012-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.